Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007607
Filing Date
2024-05-09
Accepted
2024-05-09 16:08:56
Documents
85
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vstm-20240331x10q.htm   iXBRL 10-Q 1427576
2 EX-31.1 vstm-20240331xex31d1.htm EX-31.1 12979
3 EX-31.2 vstm-20240331xex31d2.htm EX-31.2 13285
4 EX-32.1 vstm-20240331xex32d1.htm EX-32.1 7914
5 EX-32.2 vstm-20240331xex32d2.htm EX-32.2 7952
6 EX-99.1 vstm-20240331xex99d1.htm EX-99.1 198718
7 GRAPHIC vstm-20240331xex99d1001.jpg GRAPHIC 8761
  Complete submission text file 0001558370-24-007607.txt   7778009

Data Files

Seq Description Document Type Size
8 EX-101.SCH vstm-20240331.xsd EX-101.SCH 59112
9 EX-101.CAL vstm-20240331_cal.xml EX-101.CAL 61307
10 EX-101.DEF vstm-20240331_def.xml EX-101.DEF 274765
11 EX-101.LAB vstm-20240331_lab.xml EX-101.LAB 489334
12 EX-101.PRE vstm-20240331_pre.xml EX-101.PRE 427729
89 EXTRACTED XBRL INSTANCE DOCUMENT vstm-20240331x10q_htm.xml XML 1256241
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 24930590
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)